Results 201 to 210 of about 110,567 (316)

Emphysematous pyelonephritis: The silent March to mycotic aortic aneurysm- A catastrophic vascular complication in a diabetic patient. [PDF]

open access: yesUrol Case Rep
Nirmal KP   +8 more
europepmc   +1 more source

Nebivolol Protects the Thoracic and Abdominal Aorta and Their Perivascular Adipose Tissue From the Differential Detrimental Effects of Obesity

open access: yesFundamental &Clinical Pharmacology, Volume 40, Issue 4, July 2026.
ABSTRACT The effects of obesity on the vasculature and perivascular adipose tissue (PVAT) function vary according to the vascular territory. Nebivolol is a third‐generation β‐blocker that exerts vasculoprotective effects in obesity. The thoracic and abdominal aorta show different responses under physiological conditions, and their PVATs have a ...
Thales M. H. Dourado   +5 more
wiley   +1 more source

Macrophage Mayhem in Aortic Aneurysm. [PDF]

open access: yesJACC Basic Transl Sci
Nahrendorf M, Robbins C.
europepmc   +1 more source

Inflammatory Stewardship—A Perspective for Active Management of Acute Inflammation

open access: yesThe FASEB Journal, Volume 40, Issue 12, 30 June 2026.
Inflammatory stewardship frames inflammation as a manageable clinical domain requiring explicit strategy, governance, and feedback. It aligns diagnostics, risk stratification, biomarker interpretation, and immunomodulatory decisions across perioperative and critical‐care teams.
Lennart Finn Herrlich   +2 more
wiley   +1 more source

Capnocytophaga canimorsus-Induced Sepsis Unmasking an Aortic Aneurysm: A Case Report. [PDF]

open access: yesCureus
Barrigas M   +5 more
europepmc   +1 more source

CDK4/6 Inhibition Induces CD8+ T Cell Antitumor Immunity via MIF‐Induced Functional Orchestration of Tumor‐Associated Macrophages

open access: yesAdvanced Science, Volume 13, Issue 35, 24 June 2026.
CDK4/6 inhibition promotes CD8+ T cell expansion through tumor‐macrophage crosstalk by activating HIF‐1α and enhancing MIF‐CD44/CD74 signaling. This reprograms TAMs to boost MHC‐I antigen presentation, and CDK4/6 inhibitor‐trained M1 TAM supernatant therapy synergizes with low‐dose PD‐1 blockade to restore antitumor immunity.
Lin He   +17 more
wiley   +1 more source

Radiotherapy and Cardiovascular Disease Survival Risk in Non‐Small Cell Lung Cancer: A Population‐Based Study From the Surveillance, Epidemiology, and End Results Database

open access: yesCancer Medicine, Volume 15, Issue 6, June 2026.
ABSTRACT Background It is well known that radiotherapy increases the cardiovascular risk of cancer patients, but there are few large‐sample studies with cardiovasular‐specific death as the endpoint in lung cancer patients. Methods Patients aged ≥ 18 years diagnosed with non‐small cell lung cancer were retrospectively enrolled from the Surveillance ...
Li Liu   +7 more
wiley   +1 more source

New‐Onset Acute Heart Failure With Reduced Ejection Fraction Associated With Severe Microcytic Anemia

open access: yesClinical Case Reports, Volume 14, Issue 6, June 2026.
Graphical abstract summarizing a case of new‐onset HFrEF associated with profound microcytic anemia, highlighting severe anemia as a potential reversible trigger of acute cardiac decompensation. ABSTRACT Severe microcytic anemia may serve as a potentially reversible precipitating factor in heart failure with reduced ejection fraction (HFrEF). This case
Annabel Ricci   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy